Please advise by COB today 3/21: Additional questions related to SRG review of EHA grant
Reading Room Production, pp.197-198 · reading_room:email:00179
Page text: p.197, p.198 · original PDF
- Date
- 2023-03-21 10:37
- Type
- email · email
- cc
- Hugh Auchincloss, Hugh, Harper, Jill, Billet, Courtney, Emily Erbelding, Kelly, Gilles, Sharon
- sender
- Sara Selgrade
- to
- Robert Eiss, Linde, Emily
This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.
Good morning,
Background
kely to
ded questions below):
d. Did
2re
ding this?
ovide any edits or comments.
If these questions are better referred to
NIH/NIAID) [E]
jitional documentation or have any
ew of the initial RO1 grant.
nsive to this request.
As you recall, NIH OLPA reached out recently to make us aware of congressional requests for documents related to
Scientific Review Group (SRG) review of the original and renewal EHA award. NIH OLPA has indicated that HHS is likely to
provide these to the congressional requestors later this week.
NIH OLPA has drafted the attached "media statement" that notes a few potential vulnerabilities from comments in the
summary statements. They have asked us if we have additional information on these points (bolded questions below):
Vulnerabilities:
1. In the 2013 review, critique number 3 mentions that a potential overlap with PREDICT was noted. Does NIAID
have additional information that we could share about how it was determined this was not double billing?
2. In the same critique, there is a note that the potential risk to human subjects is not fully addressed. Did
NIAID work with the grantee to address these concerns before funding?
3. In the 2019 review, critique number 2 mentions that the letters from the two Chinese institutions were
identical. Do you know if there was follow-up regarding this?
Action Item
By COB today, Tuesday March 21, please review the "media statement" document and provide any edits or comments.
Please also provide any information responsive to the bolded questions above. If these questions are better referred to
OER or other NIH components, please let us know.
Thanks,
Sara
_____________________________________________